Quick Takeaways
- This page summarizes John E. Davis's Form 4 filing for ARTIVION, INC. (AORT).
- 6 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 18 Nov 2025, 13:03.
John E. Davis - 14 Nov 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)
- Signature
- /s/ John E. Davis
- Issuer symbol
- AORT
- Transactions as of
- 14 Nov 2025
- Net transactions value
- -$195,641
- Form type
- 4
- Filing time
- 18 Nov 2025, 13:03:12 UTC
- Previous filing
- 14 Nov 2025
- Next filing
- 17 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"John E. Davis filed Form 4 for ARTIVION, INC. (AORT) on 18 Nov 2025."
What Changed
- Previous filing in this sequence was filed on 14 Nov 2025.
- Current net transaction value: -$195,641.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Davis John E | Chief Commercial Officer | 1655 ROBERTS BLVD., NW, KENNESAW | /s/ John E. Davis | 18 Nov 2025 | 0001653206 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Options Exercise | $189,361 | +6,393 | +3.2% | $29.62 | 205,235 | 14 Nov 2025 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $285,575 | -6,393 | -3.1% | $44.67 | 198,842 | 14 Nov 2025 | Direct | F1 |
| transaction | AORT | Common Stock | Options Exercise | $189,390 | +6,394 | +3.2% | $29.62 | 205,236 | 17 Nov 2025 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $288,817 | -6,394 | -3.1% | $45.17 | 198,842 | 17 Nov 2025 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Stock Options (Right to buy) | Options Exercise | $0 | -6,393 | -100% | $0.000000 | 0 | 14 Nov 2025 | Common Stock | 6,393 | $29.62 | Direct | F1, F2 |
| transaction | AORT | Stock Options (Right to buy) | Options Exercise | $0 | -6,394 | -100% | $0.000000 | 0 | 17 Nov 2025 | Common Stock | 6,394 | $29.62 | Direct | F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. |
| F2 | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020. |